References

BMJ Best Practice. Sickle cell anaemia. 2022. https//bestpractice.bmj.com/topics/en-gb/100/differentials (accessed 10 May 2022)

Brandow AM, Carroll CP, Creary S American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020; 4:(12)2656-2701 https://doi.org/10.1182/bloodadvances.2020001851

Braun CA, Anderson CM. Applied pathophysiology: a conceptual approach to the mechanisms of disease, 3rd edn. Baltimore (MD): Wolters Kluwer Health; 2017

Sickle cell disease. 2020. https//tinyurl.com/4knkvuwx (accessed 10 May 2022)

Brown SN, Kumar D, James C. JRCALC clinical guidelines 2019.Bridgwater: Class Professional Publishing; 2019

Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Adv Exp Med Biol. 2010; 686:77-86 https://doi.org/10.1007/978-90-481-9485-8_5

Cohn RM, Roth KS. Biochemistry and disease: bridging basic science and clinical practice.Baltimore (MD): Williams and Wilkins; 1996

Conran N, Belcher JD. Inflammation in sickle cell disease. Clin Hemorheol Microcirc. 2018; 68:(2–3)263-299 https://doi.org/10.3233/CH-189012

Cook CE, Décary S. Higher order thinking about differential diagnosis. Braz J Phys Ther. 2020; 24:(1)1-7 https://doi.org/10.1016/j.bjpt.2019.01.010

Corwin EJ. Handbook of pathophysiology, 3rd edn. Philadelphia (PA): Lippincott Williams & Wilkins; 2008

Desprairies C, Imbard A, Koehl B Nitrous oxide and vitamin B12 in sickle cell disease: not a laughing situation. Mol Genet Metab Rep. 2020; 23 https://doi.org/10.1016/j.ymgmr.2020.100579

Dormandy E, James J, Inusa B, Rees D. How many people have sickle cell disease in the UK?. J Public Health (Oxf). 2018; 40:(3)e291-e295 https://doi.org/10.1093/pubmed/fdx172

The endothelium: part 1: multiple functions of the endothelial cells—focus on endothelium-derived vasoactive mediators. 2011. https//www.ncbi.nlm.nih.gov/books/NBK57149/ (accessed 10 May 2022)

Health and Care Professions Council. Paramedics. The standards of proficiency for paramedics. 2018. https//tinyurl.com/yc77wcrk (accessed 10 May 2022)

Howard J. Sickle cell disease: when and how to transfuse. Hematology Am Soc Hematol Educ Program. 2016; 2016:(1)625-631 https://doi.org/10.1182/asheducation-2016.1.625

Jain S, Bakshi N, Krishnamurti L. Acute chest syndrome in children with sickle cell disease. Pediatr Allergy Immunol Pulmonol. 2017; 30:(4)191-201 https://doi.org/10.1089/ped.2017.0814

Kanter SL. Case studies in academic medicine. Acad Med. 2010; 85:(4) https://doi.org/10.1097/ACM.0b013e3181d953f3

Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017; 127:(3)750-760 https://doi.org/10.1172/JCI89741

Lubeck D, Agodoa I, Bhakta N Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Netw Open. 2019; 2:(11) https://doi.org/10.1001/jamanetworkopen.2019.15374

Sickle cell disease. 2021. https//emedicine.medscape.com/article/205926-overview (accessed 10 May 2022)

Sickle cell disease differential diagnoses. 2020. https//emedicine.medscape.com/article/205926-differential (accessed 10 May 2022)

Manwani D, Frenette PS. Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies. Blood. 2013; 122:(24)3892-3898 https://doi.org/10.1182/blood-2013-05-498311

NHS. Sickle cell disease. 2019. https//www.nhs.uk/conditions/sickle-cell-disease/ (accessed 10 May 2022)

National Institute for Health and Care Excellence. Sickle cell disease: managing acute painful episodes in hospital. Clinical guideline [CG143]. 2012. https//www.nice.org.uk/guidance/cg143 (accessed 10 May 2022)

Okomo U, Meremikwu MM. Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. Cochrane Database Syst Rev. 2017; 7:(7) https://doi.org/10.1002/14651858.CD005406.pub5

Okpala I, Tawil A. Management of pain in sickle-cell disease. J R Soc Med. 2002; 95:(9)456-458

Onimoe G, Rotz S. Sickle cell disease: a primary care update. Cleve Clin J Med. 2020; 87:(1)19-27 https://doi.org/10.3949/ccjm.87a.18051

Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019; 14:263-292 https://doi.org/10.1146/annurev-pathmechdis-012418-012838

Teixeira RS, Terse-Ramos R, Ferreira TA Associations between endothelial dysfunction and clinical and laboratory parameters in children and adolescents with sickle cell anemia. PLoS One. 2017; 12:(9) https://doi.org/10.1371/journal.pone.0184076

The interaction of social, behavioral, and genetic factors in sickle cell disease. 2006. https//www.ncbi.nlm.nih.gov/books/NBK19938/ (accessed 10 May 2022)

Prehospital management of sickle cell crisis: a case report

02 June 2022
Volume 14 · Issue 6

Abstract

Sickle cell disease (SCD) covers a group of inherited conditions that affect the red blood cells. It can cause episodes of intense pain called sickle cell crises. This case study outlines a 10-year-old boy's first presentation of sickle cell crisis. The patient presents with typical sickle cell crisis pain in joints that is exacerbated by movement and related to strenuous physical exercise in the cold. This pain is caused by the sickled red blood cells occluding the microvasculature, causing tissue ischaemia. SCD is a serious disease and requires early recognition through robust clinical assessment to reduce the potential for fatality, complications and morbidity. Understanding the pathology of disease ensures paramedics work appropriately, using their knowledge to identify a patient with SCD and using skills to inform practice. Initiating the correct treatment is paramount in reducing the likelihood of fatal complications.

Sickle cell disease (SCD) is the name given to a group of inherited conditions affecting the red blood cells (erythrocytes). It causes anaemia, episodes of intense pain, as well as conditions such as acute chest syndrome, splenomegaly, gallstones, sight loss and others (Dormandy et al, 2018). SCD increases the utilisation of health services and causes severe lifestyle problems. This is owing to the complexities of treatment alongside factors such as a decrease in social activities because of exacerbated SCD conditions (Thompson, 2006).

It is estimated that people with SCD will live 22 years less than those without SCD because of the chronic complications associated with the disease, which also translate to a reduction in lifetime income (Lubeck et al, 2019).

These long-term complications affect vital organs causing splenic and renal impairment, increased susceptibility to infections and pulmonary hypertension leading to acute chest syndrome (ACS). All of these contribute to declining health and, in some situations, death (Onimoe and Rotz, 2020).

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed